Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial.

Sevene E, Banda CG, Mukaka M, Maculuve S, Macuacua S, Vala A, Piqueras M, Kalilani-Phiri L, Mallewa J, Terlouw DJ, Khoo SH, Lalloo DG, Mwapasa V.

Malar J. 2019 Aug 20;18(1):277. doi: 10.1186/s12936-019-2909-5.

2.

Systematic review of analytical methods applied to longitudinal studies of malaria.

Stanley CC, Kazembe LN, Mukaka M, Otwombe KN, Buchwald AG, Hudgens MG, Mathanga DP, Laufer MK, Chirwa TF.

Malar J. 2019 Jul 29;18(1):254. doi: 10.1186/s12936-019-2885-9.

3.

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.

van der Pluijm RW, Imwong M, Chau NH, Hoa NT, Thuy-Nhien NT, Thanh NV, Jittamala P, Hanboonkunupakarn B, Chutasmit K, Saelow C, Runjarern R, Kaewmok W, Tripura R, Peto TJ, Yok S, Suon S, Sreng S, Mao S, Oun S, Yen S, Amaratunga C, Lek D, Huy R, Dhorda M, Chotivanich K, Ashley EA, Mukaka M, Waithira N, Cheah PY, Maude RJ, Amato R, Pearson RD, Gonçalves S, Jacob CG, Hamilton WL, Fairhurst RM, Tarning J, Winterberg M, Kwiatkowski DP, Pukrittayakamee S, Hien TT, Day NP, Miotto O, White NJ, Dondorp AM.

Lancet Infect Dis. 2019 Jul 22. pii: S1473-3099(19)30391-3. doi: 10.1016/S1473-3099(19)30391-3. [Epub ahead of print]

4.

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers.

von Seidlein L, Hanboonkunupakarn B, Jittamala P, Pongsuwan P, Chotivanich K, Tarning J, Hoglund RM, Winterberg M, Mukaka M, Peerawaranun P, Sirithiranont P, Doran Z, Ockenhouse CF, Ivinson K, Lee C, Birkett AJ, Kaslow DC, Singhasivanon P, Day NPJ, Dondorp AM, White NJ, Pukrittayakamee S.

Hum Vaccin Immunother. 2019 Aug 15:1-9. doi: 10.1080/21645515.2019.1643675. [Epub ahead of print]

PMID:
31306084
5.

Joint modelling of time-to-clinical malaria and parasite count in a cohort in an endemic area.

Stanley CC, Kazembe LN, Buchwald AG, Mukaka M, Mathanga DP, Hudgens MG, Laufer MK, Chirwa TF.

J Med Stat Inform. 2019;7. pii: 1. doi: 10.7243/2053-7662-7-1.

6.

Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults.

Hanboonkunupakarn B, van der Pluijm RW, Hoglund R, Pukrittayakamee S, Winterberg M, Mukaka M, Waithira N, Chotivanich K, Singhasivanon P, White NJ, Dondorp AM, Tarning J, Jittamala P.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00060-19. doi: 10.1128/AAC.00060-19. Print 2019 Aug.

7.

Efficacy and safety of artemether-lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial.

Banda CG, Chaponda M, Mukaka M, Mulenga M, Hachizovu S, Kabuya JB, Mulenga J, Sikalima J, Kalilani-Phiri L, Terlouw DJ, Khoo SH, Lalloo DG, Mwapasa V.

Malar J. 2019 May 24;18(1):180. doi: 10.1186/s12936-019-2818-7.

8.

Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-Region.

Pell CL, Adhikari B, Myo Thwin M, Kajeechiwa L, Nosten S, Nosten FH, Sahan KM, Smithuis FM, Nguyen TN, Hien TT, Tripura R, Peto TJ, Sanann N, Nguon C, Pongvongsa T, Phommasone K, Mayxay M, Mukaka M, Peerawaranun P, Kaehler N, Cheah PY, Day NPJ, White NJ, Dondorp AM, von Seidlein L.

PLoS One. 2019 Mar 25;14(3):e0214280. doi: 10.1371/journal.pone.0214280. eCollection 2019.

9.

The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians.

Dysoley L, Kim S, Lopes S, Khim N, Bjorges S, Top S, Huch C, Rekol H, Westercamp N, Fukuda MM, Hwang J, Roca-Feltrer A, Mukaka M, Menard D, Taylor WR.

BMC Infect Dis. 2019 Mar 12;19(1):250. doi: 10.1186/s12879-019-3862-1.

10.

The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.

von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, Pongvongsa T, Lwin KM, Keereecharoen L, Kajeechiwa L, Thwin MM, Parker DM, Wiladphaingern J, Nosten S, Proux S, Corbel V, Tuong-Vy N, Phuc-Nhi TL, Son DH, Huong-Thu PN, Tuyen NTK, Tien NT, Dong LT, Hue DV, Quang HH, Nguon C, Davoeung C, Rekol H, Adhikari B, Henriques G, Phongmany P, Suangkanarat P, Jeeyapant A, Vihokhern B, van der Pluijm RW, Lubell Y, White LJ, Aguas R, Promnarate C, Sirithiranont P, Malleret B, Rénia L, Onsjö C, Chan XH, Chalk J, Miotto O, Patumrat K, Chotivanich K, Hanboonkunupakarn B, Jittmala P, Kaehler N, Cheah PY, Pell C, Dhorda M, Imwong M, Snounou G, Mukaka M, Peerawaranun P, Lee SJ, Simpson JA, Pukrittayakamee S, Singhasivanon P, Grobusch MP, Cobelens F, Smithuis F, Newton PN, Thwaites GE, Day NPJ, Mayxay M, Hien TT, Nosten FH, Dondorp AM, White NJ.

PLoS Med. 2019 Feb 15;16(2):e1002745. doi: 10.1371/journal.pmed.1002745. eCollection 2019 Feb.

11.

Peste des Petits Ruminants (PPR) virus serological surveillance in goats in Lao PDR: Issues for disease eradication in a low-resource disease-free setting.

Burns RJL, Douangngeun B, Theppangna W, Mukaka M, Wegner MD, Windsor PA, Blacksell SD.

Transbound Emerg Dis. 2019 Mar;66(2):939-947. doi: 10.1111/tbed.13109. Epub 2019 Jan 10.

PMID:
30578618
12.

Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial.

Althaus T, Greer RC, Swe MMM, Cohen J, Tun NN, Heaton J, Nedsuwan S, Intralawan D, Sumpradit N, Dittrich S, Doran Z, Waithira N, Thu HM, Win H, Thaipadungpanit J, Srilohasin P, Mukaka M, Smit PW, Charoenboon EN, Haenssgen MJ, Wangrangsimakul T, Blacksell S, Limmathurotsakul D, Day N, Smithuis F, Lubell Y.

Lancet Glob Health. 2019 Jan;7(1):e119-e131. doi: 10.1016/S2214-109X(18)30444-3.

13.

The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos.

Pongvongsa T, Phommasone K, Adhikari B, Henriques G, Chotivanich K, Hanboonkunupakarn B, Mukaka M, Peerawaranun P, von Seidlein L, Day NPJ, White NJ, Dondorp AM, Imwong M, Newton PN, Singhasivanon P, Mayxay M, Pukrittayakamee S.

Malar J. 2018 Nov 3;17(1):405. doi: 10.1186/s12936-018-2541-9.

14.

Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy.

Banda CG, Dzinjalamala F, Mukaka M, Mallewa J, Maiden V, Terlouw DJ, Lalloo DG, Khoo SH, Mwapasa V.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01162-18. doi: 10.1128/AAC.01162-18. Print 2018 Nov.

15.

Identifying risk factors for the development of sepsis during adult severe malaria.

Njim T, Dondorp A, Mukaka M, Ohuma EO.

Malar J. 2018 Jul 31;17(1):278. doi: 10.1186/s12936-018-2430-2.

16.

Retrospective review of the management of acute infections and the indications for antibiotic prescription in primary care in northern Thailand.

Greer RC, Intralawan D, Mukaka M, Wannapinij P, Day NPJ, Nedsuwan S, Lubell Y.

BMJ Open. 2018 Jul 30;8(7):e022250. doi: 10.1136/bmjopen-2018-022250.

18.

Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar.

Tun KM, Jeeyapant A, Myint AH, Kyaw ZT, Dhorda M, Mukaka M, Cheah PY, Imwong M, Hlaing T, Kyaw TH, Ashley EA, Dondorp A, White NJ, Day NPJ, Smithuis F.

Malar J. 2018 Jul 11;17(1):258. doi: 10.1186/s12936-018-2404-4.

19.

Causes of acute undifferentiated fever and the utility of biomarkers in Chiangrai, northern Thailand.

Wangrangsimakul T, Althaus T, Mukaka M, Kantipong P, Wuthiekanun V, Chierakul W, Blacksell SD, Day NP, Laongnualpanich A, Paris DH.

PLoS Negl Trop Dis. 2018 May 31;12(5):e0006477. doi: 10.1371/journal.pntd.0006477. eCollection 2018 May.

20.

Affordable house designs to improve health in rural Africa: a field study from northeastern Tanzania.

von Seidlein L, Ikonomidis K, Mshamu S, Nkya TE, Mukaka M, Pell C, Lindsay SW, Deen JL, Kisinza WN, Knudsen JB.

Lancet Planet Health. 2017 Aug;1(5):e188-e199. doi: 10.1016/S2542-5196(17)30078-5. Epub 2017 Aug 4. Erratum in: Lancet Planet Health. 2017 Sep;1(6):e220.

21.

Pharmacokinetics of Piperaquine and Safety Profile of Dihydroartemisinin-Piperaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults.

Banda CG, Dzinjalamala F, Mukaka M, Mallewa J, Maiden V, Terlouw DJ, Lalloo DG, Khoo SH, Mwapasa V.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00634-18. doi: 10.1128/AAC.00634-18. Print 2018 Aug.

22.

Pharmacokinetics and Safety Profile of Artesunate-Amodiaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults.

Banda CG, Dzinjalamala F, Mukaka M, Mallewa J, Maiden V, Terlouw DJ, Lalloo DG, Khoo SH, Mwapasa V.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00412-18. doi: 10.1128/AAC.00412-18. Print 2018 Jul.

23.

Serosurveillance of Coxiellosis (Q-fever) and Brucellosis in goats in selected provinces of Lao People's Democratic Republic.

Burns RJL, Douangngeun B, Theppangna W, Khounsy S, Mukaka M, Selleck PW, Hansson E, Wegner MD, Windsor PA, Blacksell SD.

PLoS Negl Trop Dis. 2018 Apr 12;12(4):e0006411. doi: 10.1371/journal.pntd.0006411. eCollection 2018 Apr.

24.

Scrub typhus point-of-care testing: A systematic review and meta-analysis.

Saraswati K, Day NPJ, Mukaka M, Blacksell SD.

PLoS Negl Trop Dis. 2018 Mar 26;12(3):e0006330. doi: 10.1371/journal.pntd.0006330. eCollection 2018 Mar. Review.

25.

A Competing-Risk Approach for Modeling Length of Stay in Severe Malaria Patients in South-East Asia and the Implications for Planning of Hospital Services.

Keene CM, Dondorp A, Crawley J, Ohuma EO, Mukaka M.

Clin Infect Dis. 2018 Sep 14;67(7):1053-1062. doi: 10.1093/cid/ciy211.

26.

Acetaminophen as a Renoprotective Adjunctive Treatment in Patients With Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial.

Plewes K, Kingston HWF, Ghose A, Wattanakul T, Hassan MMU, Haider MS, Dutta PK, Islam MA, Alam S, Jahangir SM, Zahed ASM, Sattar MA, Chowdhury MAH, Herdman MT, Leopold SJ, Ishioka H, Piera KA, Charunwatthana P, Silamut K, Yeo TW, Lee SJ, Mukaka M, Maude RJ, Turner GDH, Faiz MA, Tarning J, Oates JA, Anstey NM, White NJ, Day NPJ, Hossain MA, Roberts Ii LJ, Dondorp AM.

Clin Infect Dis. 2018 Sep 14;67(7):991-999. doi: 10.1093/cid/ciy213.

27.

A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages.

Tripura R, Peto TJ, Chea N, Chan D, Mukaka M, Sirithiranont P, Dhorda M, Promnarate C, Imwong M, von Seidlein L, Duanguppama J, Patumrat K, Huy R, Grobusch MP, Day NPJ, White NJ, Dondorp AM.

Clin Infect Dis. 2018 Aug 31;67(6):817-826. doi: 10.1093/cid/ciy196.

28.

The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study.

Nguyen TN, von Seidlein L, Nguyen TV, Truong PN, Hung SD, Pham HT, Nguyen TU, Le TD, Dao VH, Mukaka M, Day NP, White NJ, Dondorp AM, Thwaites GE, Hien TT.

Lancet Infect Dis. 2018 May;18(5):565-572. doi: 10.1016/S1473-3099(18)30046-X. Epub 2018 Feb 2. Erratum in: Lancet Infect Dis. 2018 May;18(5):492.

29.

Presence of B. thailandensis and B. thailandensis expressing B. pseudomallei-like capsular polysaccharide in Thailand, and their associations with serological response to B. pseudomallei.

Hantrakun V, Thaipadungpanit J, Rongkard P, Srilohasin P, Amornchai P, Langla S, Mukaka M, Chantratita N, Wuthiekanun V, Dance DAB, Day NPJ, Peacock SJ, Limmathurotsakul D.

PLoS Negl Trop Dis. 2018 Jan 24;12(1):e0006193. doi: 10.1371/journal.pntd.0006193. eCollection 2018 Jan.

30.

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.

Taylor WR, Naw HK, Maitland K, Williams TN, Kapulu M, D'Alessandro U, Berkley JA, Bejon P, Okebe J, Achan J, Amambua AN, Affara M, Nwakanma D, van Geertruyden JP, Mavoko M, Lutumba P, Matangila J, Brasseur P, Piola P, Randremanana R, Lasry E, Fanello C, Onyamboko M, Schramm B, Yah Z, Jones J, Fairhurst RM, Diakite M, Malenga G, Molyneux M, Rwagacondo C, Obonyo C, Gadisa E, Aseffa A, Loolpapit M, Henry MC, Dorsey G, John C, Sirima SB, Barnes KI, Kremsner P, Day NP, White NJ, Mukaka M.

BMC Med. 2018 Jan 18;16(1):11. doi: 10.1186/s12916-017-0990-6.

31.

Goal directed therapy for suspected acute bacterial meningitis in adults and adolescents in sub-Saharan Africa.

Wall EC, Mukaka M, Denis B, Mlozowa VS, Msukwa M, Kasambala K, Nyrienda M, Allain TJ, Faragher B, Heyderman RS, Lalloo DG.

PLoS One. 2017 Oct 27;12(10):e0186687. doi: 10.1371/journal.pone.0186687. eCollection 2017.

32.

Simplified prognostic model for critically ill patients in resource limited settings in South Asia.

Haniffa R, Mukaka M, Munasinghe SB, De Silva AP, Jayasinghe KSA, Beane A, de Keizer N, Dondorp AM.

Crit Care. 2017 Oct 17;21(1):250. doi: 10.1186/s13054-017-1843-6.

33.

Applicability of the APACHE II model to a lower middle income country.

Haniffa R, Pubudu De Silva A, Weerathunga P, Mukaka M, Athapattu P, Munasinghe S, Mahesh B, Mahipala P, De Silva T, Abayadeera A, Jayasinghe S, de Keizer N, Dondorp AM.

J Crit Care. 2017 Dec;42:178-183. doi: 10.1016/j.jcrc.2017.07.022. Epub 2017 Jul 13.

PMID:
28755619
34.

Rabies surveillance in dogs in Lao PDR from 2010-2016.

Douangngeun B, Theppangna W, Phommachanh P, Chomdara K, Phiphakhavong S, Khounsy S, Mukaka M, Dance DAB, Blacksell SD.

PLoS Negl Trop Dis. 2017 Jun 1;11(6):e0005609. doi: 10.1371/journal.pntd.0005609. eCollection 2017 Jun.

35.
36.

Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study.

Plewes K, Kingston HWF, Ghose A, Maude RJ, Herdman MT, Leopold SJ, Ishioka H, Hasan MMU, Haider MS, Alam S, Piera KA, Charunwatthana P, Silamut K, Yeo TW, Faiz MA, Lee SJ, Mukaka M, Turner GDH, Anstey NM, Jackson Roberts L 2nd, White NJ, Day NPJ, Hossain MA, Dondorp AM.

BMC Infect Dis. 2017 Apr 27;17(1):313. doi: 10.1186/s12879-017-2373-1.

37.

Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.

Leang R, Khu NH, Mukaka M, Debackere M, Tripura R, Kheang ST, Chy S, Kak N, Buchy P, Tarantola A, Menard D, Roca-Felterer A, Fairhurst RM, Kheng S, Muth S, Ngak S, Dondorp AM, White NJ, Taylor WR.

BMC Med. 2016 Dec 20;14(1):213. No abstract available.

38.

Prediction of Outcome From Adult Bacterial Meningitis in a High-HIV-Seroprevalence, Resource-Poor Setting Using the Malawi Adult Meningitis Score (MAMS).

Wall EC, Mukaka M, Scarborough M, Ajdukiewicz KMA, Cartwright KE, Nyirenda M, Denis B, Allain TJ, Faragher B, Lalloo DG, Heyderman RS.

Clin Infect Dis. 2017 Feb 15;64(4):413-419. doi: 10.1093/cid/ciw779.

39.

An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.

Leang R, Khu NH, Mukaka M, Debackere M, Tripura R, Kheang ST, Chy S, Kak N, Buchy P, Tarantola A, Menard D, Roca-Felterer A, Fairhurst RM, Kheng S, Muth S, Ngak S, Dondorp AM, White NJ, Taylor WR.

BMC Med. 2016 Oct 27;14(1):171. Erratum in: BMC Med. 2016 Dec 20;14 (1):213.

40.

Is using multiple imputation better than complete case analysis for estimating a prevalence (risk) difference in randomized controlled trials when binary outcome observations are missing?

Mukaka M, White SA, Terlouw DJ, Mwapasa V, Kalilani-Phiri L, Faragher EB.

Trials. 2016 Jul 22;17:341. doi: 10.1186/s13063-016-1473-3.

41.

HIV coinfection influences the inflammatory response but not the outcome of cerebral malaria in Malawian children.

Mbale EW, Moxon CA, Mukaka M, Chagomerana M, Glover S, Chisala N, Omar S, Molyneux M, Seydel K, Craig AG, Taylor T, Heyderman RS, Mallewa M.

J Infect. 2016 Sep;73(3):189-99. doi: 10.1016/j.jinf.2016.05.012. Epub 2016 Jun 14. Review.

42.

High mortality and prevalence of HIV and tuberculosis in adults with chronic cough in Malawi: a cohort study.

Nliwasa M, MacPherson P, Mukaka M, Mdolo A, Mwapasa M, Kaswaswa K, Msefula C, Chipungu G, Mwandumba HC, Corbett EL.

Int J Tuberc Lung Dis. 2016 Feb;20(2):202-10. doi: 10.5588/ijtld.15.0388.

43.

Risk factors for Anopheles mosquitoes in rural and urban areas of Blantyre District, southern Malawi.

Mzilahowa T, Luka-Banda M, Uzalili V, Mathanga DP, Campbell CH Jr, Mukaka M, Gimnig JE.

Malawi Med J. 2016 Dec;28(4):154-158.

44.

Differential PfEMP1 expression is associated with cerebral malaria pathology.

Tembo DL, Nyoni B, Murikoli RV, Mukaka M, Milner DA, Berriman M, Rogerson SJ, Taylor TE, Molyneux ME, Mandala WL, Craig AG, Montgomery J.

PLoS Pathog. 2014 Dec 4;10(12):e1004537. doi: 10.1371/journal.ppat.1004537. eCollection 2014 Dec.

45.

Subtle changes in Plasmodium falciparum infection complexity following enhanced intervention in Malawi.

Sisya TJ, Kamn'gona RM, Vareta JA, Fulakeza JM, Mukaka MF, Seydel KB, Laufer MK, Taylor TE, Nkhoma SC.

Acta Trop. 2015 Feb;142:108-14. doi: 10.1016/j.actatropica.2014.11.008. Epub 2014 Nov 25.

46.

Mother-infant pair clinic and SMS messaging as innovative strategies for improving access to and retention in eMTCT care and Option B+ in Malawi: a cluster randomized control trial (the PRIME study).

Mwapasa V, Pro G, Chinkhumba J, Mukaka M, Kobayashi E, Stuart A, Gunda A, Joseph J, Sugandhi N, Chimbwandira FM, Eliya M.

J Acquir Immune Defic Syndr. 2014 Nov 1;67 Suppl 2:S120-4. doi: 10.1097/QAI.0000000000000327.

PMID:
25310117
47.

Sepsis carries a high mortality among hospitalised adults in Malawi in the era of antiretroviral therapy scale-up: a longitudinal cohort study.

Waitt PI, Mukaka M, Goodson P, SimuKonda FD, Waitt CJ, Feasey N, Allain TJ, Downie P, Heyderman RS.

J Infect. 2015 Jan;70(1):11-9. doi: 10.1016/j.jinf.2014.07.004. Epub 2014 Jul 17.

48.

Genomic pneumococcal load and CSF cytokines are not related to outcome in Malawian adults with meningitis.

Wall EC, Gritzfeld JF, Scarborough M, Ajdukiewicz KM, Mukaka M, Corless C, Lalloo DG, Gordon SB.

J Infect. 2014 Nov;69(5):440-6. doi: 10.1016/j.jinf.2014.06.011. Epub 2014 Jun 26.

49.

Viral CNS infections in children from a malaria-endemic area of Malawi: a prospective cohort study.

Mallewa M, Vallely P, Faragher B, Banda D, Klapper P, Mukaka M, Khofi H, Pensulo P, Taylor T, Molyneux M, Solomon T.

Lancet Glob Health. 2013 Sep;1(3):e153-60.

50.

A reduction in adult blood stream infection and case fatality at a large African hospital following antiretroviral therapy roll-out.

Feasey NA, Houston A, Mukaka M, Komrower D, Mwalukomo T, Tenthani L, Jahn A, Moore M, Peters RP, Gordon MA, Everett DB, French N, van Oosterhout JJ, Allain TJ, Heyderman RS.

PLoS One. 2014 Mar 18;9(3):e92226. doi: 10.1371/journal.pone.0092226. eCollection 2014.

Supplemental Content

Loading ...
Support Center